Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Cavalla

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Neuroscience Letters|July 23, 2002
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blotDavide Schiffer, Paola Cavalla, Valentina Fiano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2018
Predicting the profile of increasing disability in multiple sclerosisValentina Tomassini, Fulvia Fanelli, Luca Prosperini, et al.
Journal of Neuro-Oncology|March 8, 2003
Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma setsChiara Ghimenti, Valentina Fiano, Loredana Chiadò-Piat, et al.
Journal of Neuropathology and Experimental Neurology|December 2, 2005
Grey matter pathology in multiple sclerosisMarco Vercellino, Federica Plano, Barbara Votta, et al.
Multiple Sclerosis and Related Disorders|April 14, 2023
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control studyMarco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Impact of COVID-19 lockdown on progressive multiple sclerosis patientsMarco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2018
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuationMaria Teresa Giordana, Paola Cavalla, Antonio Uccelli, et al.
Frontiers in Neurology|November 8, 2021
Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case SeriesStefania F De Mercanti, Marco Vercellino, Chiara Bosa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2021
Paraneoplastic neuromyelitis optica spectrum disorders: a case seriesEleonora Virgilio, Domizia Vecchio, Marco Vercellino, et al.
Journal of Neuropathology and Experimental Neurology|September 21, 2007
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damageMarco Vercellino, Aristide Merola, Chiara Piacentino, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Neuroscience Letters|July 23, 2002
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blotDavide Schiffer, Paola Cavalla, Valentina Fiano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 3, 2018
Predicting the profile of increasing disability in multiple sclerosisValentina Tomassini, Fulvia Fanelli, Luca Prosperini, et al.
Journal of Neuro-Oncology|March 8, 2003
Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma setsChiara Ghimenti, Valentina Fiano, Loredana Chiadò-Piat, et al.
Journal of Neuropathology and Experimental Neurology|December 2, 2005
Grey matter pathology in multiple sclerosisMarco Vercellino, Federica Plano, Barbara Votta, et al.
Multiple Sclerosis and Related Disorders|April 14, 2023
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control studyMarco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Impact of COVID-19 lockdown on progressive multiple sclerosis patientsMarco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2018
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuationMaria Teresa Giordana, Paola Cavalla, Antonio Uccelli, et al.
Frontiers in Neurology|November 8, 2021
Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case SeriesStefania F De Mercanti, Marco Vercellino, Chiara Bosa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2021
Paraneoplastic neuromyelitis optica spectrum disorders: a case seriesEleonora Virgilio, Domizia Vecchio, Marco Vercellino, et al.
Journal of Neuropathology and Experimental Neurology|September 21, 2007
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damageMarco Vercellino, Aristide Merola, Chiara Piacentino, et al.
Pageof 10